$JBM HEALTHCARE(02161)$  Warren once said "that buy companies that you won't mind owning if NYSE/NASDAQ closed down for a year". To me, its' JBM Healthcare. On the surface, its' an unknown newly floated issue. However, underneath, it represents a powerpack of legacy trusted chinese healthcare brands that has went through thick & thin with chinese people. Brand value resides in consumer's trust in them & on this scale, JBM's brands is of the highest quality. Revisiting Warren's quote at the beginning of this write up, JBM Healthcare has used its cashflow surpluses to eliminate debt (*yes, its a zero debt company); while returning shareholder value via a stock buyback program that ended up purchasing 10% of outstanding shares &

$HENLIUS(02696)$ #Privatisation Increasingly, this issue's take private bid by it's parent company, Fosun looks unfavorable to be voted through by it's shareholders due to a sudden index wide upwards revaluation. Coupled with a turnaround in earnings in recent quarter & the delay in getting necessary approvals from gov institution, it reduced likelihood & certainty of it going through. 

Since Mars broke the news in April that it was in advanced acquisition talks with $Kellogg's (K)$, Hershey has also expressed interest in Kellanova.The potential deal could be a major consolidation in the food industry this year.Kellanova, the snacks business unit spun off from Kellogg, has several well-known brands such as Cheez-It, Pringles and Pop-Tarts. $Hershey(HSY)$ is known for its chocolate and candy products, including brands such as Reese's, Kit Kat and Twizzlers.Mars has equally well-known brands including Dove, M&M and Snickers.While Mars appears to be in the lead in acquisition talks, Hershey also said.This suggests that Kellanova's value in the snack food market is recognized by

$Macy's (M)$ announced on Monday that it had terminated talks with Arkhouse and Brigade Capital Management, rejecting a $6.9 billion valuation for privatization, and the stock erased the gains it had made since the news broke seven months ago.For its part, the privatization buyer groupAlready holds over 5% of the shares and threatened a proxy fight with the company to gain 2 board seats, and the company side is quite cooperative, sharing very much detailed data, such as store profit and loss.The two price increases show that they still want to facilitate the acquisition.The first time from 21-24, the second a bit muddled, 24-24.9, basically did not move, the implication is that the consortium still want to buy, but do not want to give

A group of activist investors led by Arkhouse Management and Brigade Capital Management raised their offer for $Macy's(M)$ again over the weekend, the third time they have raised their offer for the retail giant.The latest offer is $24.80 per share, a small increase from the previous $24, for a total valuation of about $6.97 billion.The news pushed Macy's shares up 12.6% on July 5Takeover offer historyDecember 2023: initial offer of $21 per shareMarch 2024: offer price increased to $24 per shareJuly 2024: latest offer reaches $24.80 per shareChallenges and Opportunities for Macy'sDespite the attractive acquisition offer, Macy's faces a number of challenges:Pressure on performance: revenue declined 1.2% year-over-year in the first quar